
SEC filing red flags, week of Oct 12 to 16, 2026
1 late filing notice, 3 non reliance warnings, 5 auditor changes, 10 listing deficiency notices and 8 going concern warnings at companies listed on Nasdaq or the NYSE, each line matched to the filing.
Snapshot
From Oct 12, 2026 to Oct 16, 2026, 26 companies listed on Nasdaq or the NYSE made 27 filings on this list: 1 late filing notice, 3 non reliance warnings, 5 auditor changes, 10 listing deficiency notices and 8 going concern warnings. The largest by public float is Nurix Therapeutics (NRIX), which said in its quarterly report for the period ended August 31, 2026 that there is substantial doubt about its ability to continue as a going concern.
Market Data
| Company | 1D % | Price |
|---|---|---|
| ($NRIX) | ▲ +4.69% | 26.10 |
| ($PLMK) | ▲ +0.00% | 10.62 |
| ($ESP) | ▼ −0.24% | 53.28 |
| ($EHTH) | ▲ +2.34% | 0.58 |
| ($CYN) | ▲ +0.73% | 0.41 |
| ($GPRO) | ▲ +5.77% | 1.10 |
| ($ARAI) | ▼ −0.33% | 0.12 |
| ($LUCD) | ▼ −6.76% | 0.35 |
as of 16:00 ET · Realtime derived data
What We Know
Late filing notices. • Rocky Mountain Chocolate Factory (RMCF) filed a notice that its quarterly report for the period ended August 31, 2026 will be late. Filed Oct 14.
Non reliance on past financial statements. • GoPro (GPRO) said on October 9, 2026 that previously issued financial statements should no longer be relied upon (Item 4.02). Filed Oct 16. • EON Resources (EONR) said on October 8, 2026 that previously issued financial statements should no longer be relied upon (Item 4.02). Filed Oct 13. • High Roller Technologies (ROLR) said on October 15, 2026 that previously issued financial statements should no longer be relied upon (Item 4.02). Filed Oct 16.
Auditor changes. • Espey Mfg & Electronics (ESP) reported a change of independent auditor (Item 4.01). Filed Oct 16. • Arrive AI (ARAI) reported a change of independent auditor (Item 4.01). It reported no disagreements with the former auditor. The filing mentions a material weakness in internal control. Filed Oct 16. • PharmaCyte Biotech (PMCB) reported a change of independent auditor on October 14, 2026 (Item 4.01). The filing mentions a material weakness in internal control. Filed Oct 16. • Netcapital (NCPL) reported a change of independent auditor (Item 4.01). Filed Oct 14. • Terra Innovatum Global (NKLR) reported a change of independent auditor (Item 4.01). It reported no disagreements with the former auditor. The filing mentions a material weakness in internal control. Filed Oct 16.
Exchange listing deficiency notices. • Plum Acquisition Corp. IV (PLMK) disclosed on October 14, 2026 a notice from Nasdaq that it does not meet a continued listing requirement (Item 3.01). Filed Oct 14. • eHealth (EHTH) disclosed on October 14, 2026 a notice from Nasdaq that it does not meet the minimum bid price requirement, after its shares closed below $1.00 for 30 consecutive business days (Item 3.01). Filed Oct 16. • Cyngn (CYN) disclosed on October 14, 2026 a notice from Nasdaq that it does not meet the minimum bid price requirement, after its shares closed below $1.00 for 30 consecutive business days (Item 3.01). Filed Oct 15. • Lucid Diagnostics (LUCD) disclosed a notice from Nasdaq that it does not meet a continued listing requirement (Item 3.01). Filed Oct 16. • DataMeds AI (MEDS) disclosed a notice from Nasdaq that it does not meet the requirement to file periodic reports on time (Item 3.01). Filed Oct 16. • Quetta Acquisition (QETA) disclosed a notice from Nasdaq that it does not meet a continued listing requirement (Item 3.01). Filed Oct 13. • Bridgeline Digital (BLIN) disclosed on October 14, 2026 a notice from Nasdaq that it does not meet the minimum bid price requirement (Item 3.01). Filed Oct 16. • Health In Tech (HIT) disclosed a notice from Nasdaq that it does not meet the minimum bid price requirement (Item 3.01). Filed Oct 16. • Equus Total Return (EQS) disclosed on October 6, 2026 a notice from the NYSE that it does not meet a continued listing requirement (Item 3.01). Filed Oct 13. • Callan JMB (CJMB) disclosed a notice from Nasdaq that it does not meet the stockholders' equity requirement (Item 3.01). Filed Oct 16.
Going concern warnings. • Nurix Therapeutics (NRIX) said in its quarterly report for the period ended August 31, 2026 that there is substantial doubt about its ability to continue as a going concern. Filed Oct 13. • FingerMotion (FNGR) said in its quarterly report for the period ended August 31, 2026 that there is substantial doubt about its ability to continue as a going concern. Filed Oct 15. • Loop Industries (LOOP) said in its quarterly report for the period ended August 31, 2026 that there is substantial doubt about its ability to continue as a going concern. Filed Oct 16. • Lunai Bioworks (LNAI) said in its annual report for the period ended June 30, 2026 that there is substantial doubt about its ability to continue as a going concern. Filed Oct 13. • NextTrip (NTRP) said in its quarterly report for the period ended August 31, 2026 that there is substantial doubt about its ability to continue as a going concern. Filed Oct 15. • ChronoScale (CHRN) said in its quarterly report for the period ended August 31, 2026 that there is substantial doubt about its ability to continue as a going concern. Filed Oct 14. • EON Resources (EONR) said in its quarterly report for the period ended March 31, 2026 that there is substantial doubt about its ability to continue as a going concern. Filed Oct 13. • Treasure Global (TGL) said in its annual report for the period ended June 30, 2026 that there is substantial doubt about its ability to continue as a going concern. Filed Oct 13.
Octans View
The longest section this week is listing deficiency notices (10). A notice is a disclosure, not a verdict: many late filers file within the extension period, and auditor changes are routine at small companies. The heavier lines are non reliance warnings and going concern language, because they speak to whether past numbers can be trusted and whether the company can keep operating.
Bear Case · Room for Disagreement
Limits. The list covers companies whose primary listing is on Nasdaq or the NYSE in the SEC's company ticker file, filings dated Monday to Friday, and at most 10 companies a section, largest public float first. A listing deficiency notice usually comes with a cure period, and a late filing notice is often followed by the report within days. Amended filings are not included.
Method and source. Filings are found through EDGAR full text search by form type, current report item number (4.01, 4.02, 3.01) and, for going concern warnings, the phrase "substantial doubt" with "going concern" in a sentence that is not negated. Each line is generated from the filing by a fixed template, and every number in a line appears in the filing text. No model wrote this list.
Chart
Sources
- [1]SEC EDGAR — Rocky Mountain Chocolate Factory late filing notice for its quarterly report, filed Oct 14, 2026
- [2]SEC EDGAR — GoPro current report, filed Oct 16, 2026
- [3]SEC EDGAR — EON Resources current report, filed Oct 13, 2026
- [4]SEC EDGAR — High Roller Technologies current report, filed Oct 16, 2026
- [5]SEC EDGAR — Espey Mfg & Electronics current report, filed Oct 16, 2026
- [6]SEC EDGAR — Arrive AI current report, filed Oct 16, 2026
- [7]SEC EDGAR — PharmaCyte Biotech current report, filed Oct 16, 2026
- [8]SEC EDGAR — Netcapital current report, filed Oct 14, 2026
- [9]SEC EDGAR — Terra Innovatum Global current report, filed Oct 16, 2026
- [10]SEC EDGAR — Plum Acquisition Corp. IV current report, filed Oct 14, 2026
- [11]SEC EDGAR — eHealth current report, filed Oct 16, 2026
- [12]SEC EDGAR — Cyngn current report, filed Oct 15, 2026
- [13]SEC EDGAR — Lucid Diagnostics current report, filed Oct 16, 2026
- [14]SEC EDGAR — DataMeds AI current report, filed Oct 16, 2026
- [15]SEC EDGAR — Quetta Acquisition current report, filed Oct 13, 2026
- [16]SEC EDGAR — Bridgeline Digital current report, filed Oct 16, 2026
- [17]SEC EDGAR — Health In Tech current report, filed Oct 16, 2026
- [18]SEC EDGAR — Equus Total Return current report, filed Oct 13, 2026
- [19]SEC EDGAR — Callan JMB current report, filed Oct 16, 2026
- [20]SEC EDGAR — Nurix Therapeutics quarterly report, filed Oct 13, 2026
- [21]SEC EDGAR — FingerMotion quarterly report, filed Oct 15, 2026
- [22]SEC EDGAR — Loop Industries quarterly report, filed Oct 16, 2026
- [23]SEC EDGAR — Lunai Bioworks annual report, filed Oct 13, 2026
- [24]SEC EDGAR — NextTrip quarterly report, filed Oct 15, 2026
- [25]SEC EDGAR — ChronoScale quarterly report, filed Oct 14, 2026
- [26]SEC EDGAR — EON Resources quarterly report, filed Oct 13, 2026
- [27]SEC EDGAR — Treasure Global annual report, filed Oct 13, 2026
These are the sources this piece was drafted from. How we verify. Found an error? Tell us and we correct it in public.
More on $NRIX
4 reports
SenesTech 10% owner Glenbrook Capital Management buys $706,000 of shares
Open market purchase reported on Form 4, filed Oct 19, 2026.
Applied Digital CEO Wes Cummins buys $1.0 million of shares
Open market purchase reported on Form 4, filed Oct 19, 2026.
Bluerock Private Real Estate Fund director Ramin Kamfar buys $2.4 million of shares
Open market purchase reported on Form 4, filed Oct 19, 2026.
Applied Digital president Jason Gechen Zhang buys $5.7 million of shares
Open market purchase reported on Form 4, filed Oct 19, 2026.